Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 55,232 | 98,427 | 90,122 | 92,055 | 101,907 |
| Cost of Goods | N/A | 30,686 | 33,768 | 21,635 | 24,897 |
| Gross Profit | 55,232 | 67,741 | 56,354 | 70,420 | 77,010 |
| Operating Expenses | 195,334 | 173,625 | 320,806 | 447,221 | 524,010 |
| Operating Income | -140,102 | -105,198 | -263,684 | -376,166 | -446,103 |
| Interest Expense | 26,184 | 28,112 | 25,334 | 28,911 | 47,313 |
| Other Income | 2,072 | 14,110 | 12,762 | 40,094 | -29,864 |
| Pre-tax Income | -164,214 | -119,200 | -276,256 | -364,983 | -523,280 |
| Income Tax | -138 | -239 | -200 | 3,215 | 557 |
| Net Income Continuous | -164,076 | -118,961 | -276,056 | -368,198 | -523,837 |
| Net Income | $-164,076 | $-118,961 | $-276,056 | $-368,198 | $-523,837 |
| EPS Basic Total Ops | -9.73 | -8.68 | -21.74 | -29.54 | -42.88 |
| EPS Basic Continuous Ops | -9.73 | -8.68 | -21.78 | -29.50 | -42.85 |
| EPS Diluted Total Ops | -9.73 | -8.68 | -21.74 | -29.54 | -42.88 |
| EPS Diluted Continuous Ops | -9.73 | -8.68 | -21.78 | -29.50 | -42.85 |
| EPS Diluted Before Non-Recurring Items | -8.66 | -10.50 | -12.89 | -29.54 | -42.88 |
| EBITDA(a) | $-139,076 | $-100,807 | $-179,368 | $-363,136 | $-431,957 |